Evaluation of Surgical and Obstetric Outcomes in Pregnant Women Undergoing Operative Laparoscopy

Sponsor
Università degli Studi dell'Insubria (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05271877
Collaborator
(none)
100
24

Study Details

Study Description

Brief Summary

Laparoscopy, when applicable, is the current gold standard management for abdominal and pelvic surgery. Although accumulating evidence suggests that laparoscopy is associated with reduced intraoperative and postoperative morbidity, reduced hospital stay, better recovery and cosmesis compared with open surgery (laparotomy), the use of this technique in pregnant women is still debated. Considering this point, we aimed to collect retrospectively cases of laparoscopic surgery during pregnancy, regardless of the indication and gestational age, in order to analyze both surgical and obstetric outcomes during and after the procedure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopy

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Evaluation of Surgical and Obstetric Outcomes in Pregnant Women Undergoing Operative Laparoscopy
Anticipated Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Pregnant women

Pregnant women, regardless of the gestational age.

Procedure: Laparoscopy
Diagnostic/operative laparoscopic procedure

Outcome Measures

Primary Outcome Measures

  1. Intraoperative complication [From the beginning to the end of laparoscopy]

    Any complication during laparoscopy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pregnant women (regardless of gestational age)

  • At least one indication for laparoscopic surgery

Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Università degli Studi dell'Insubria

Investigators

  • Principal Investigator: Antonio Simone Laganà, M.D., Ph.D., Università degli Studi dell'Insubria

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Antonio Simone Laganà, M.D. Ph.D., Università degli Studi dell'Insubria
ClinicalTrials.gov Identifier:
NCT05271877
Other Study ID Numbers:
  • LAPRE-1
First Posted:
Mar 9, 2022
Last Update Posted:
Mar 9, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Antonio Simone Laganà, M.D. Ph.D., Università degli Studi dell'Insubria

Study Results

No Results Posted as of Mar 9, 2022